Persistence Market Research Company
Promotion Offer Get Report Sample

Monoclonal Antibodies Market

Monoclonal Antibodies Market Size, Share and Growth Forecast by Source Type (Human, Murine, Chimeric, Humanized), by Production Type (In-vivo, In-vitro), by Application (Infectious Diseases, Neurological Diseases, Autoimmune Diseases, Oncology, Others), by End User (Hospitals, Specialty Centers, Others), and by Region for 2024-2031

Industry: Healthcare

Published Date: June-2024

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 0

Report ID: PMRREP34600

Report Price

$4900*

Buy Now
Get Customisation

Table of Content

  1. Executive Summary
    1. Global Monoclonal Antibodies Market Snapshot, 2024 and 2031
    2. Market Opportunity Assessment, 2024 – 2031, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. Forecast Factors – Relevance and Impact
    5. Covid-19 Impact Assessment
  3. Value Added Insights
    1. Product Adoption / Usage Analysis
    2. Recent Product Launches and Approvals Insights
    3. Regulatory Landscape
    4. Pipeline Analysis
    5. Promotional Strategies, By Key Players
    6. Value Chain Analysis
    7. Porter’s Five Force’s Analysis
    8. PESTLE Analysis
    9. Parent Market Analysis
  4. Global Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
      1. Market Size and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size Analysis, 2018-2022
      2. Current Market Size Analysis and Forecast, 2023–2031
    3. Global Monoclonal Antibodies Market Outlook: Source Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis By Source Type, 2018 – 2022
      3. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
        1. Human
        2. Murine
        3. Chimeric
        4. Humanized
    4. Market Attractiveness Analysis: Source Type
    5. Global Monoclonal Antibodies Market Outlook: Production Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis By Production Type, 2018 – 2022
      3. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
        1. In Vivo
        2. In Vitro
    6. Market Attractiveness Analysis: Production Type
    7. Global Monoclonal Antibodies Market Outlook: Application 
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis By Application, 2018 – 2022
      3. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
        1. Infectious Diseases
        2. Neurological Diseases
        3. Autoimmune Diseases
        4. Oncology
        5. Others
    8. Market Attractiveness Analysis: Application 
    9. Global Monoclonal Antibodies Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis By End User, 2018 – 2022
      3. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
        1. Hospitals
        2. Specialty Centers
        3. Academical and  Research Institutes
        4. Biopharma Companies
        5. Others
    10. Market Attractiveness Analysis: End User
  5. Global Monoclonal Antibodies Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Region, 2018 – 2022
    3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 – 2031
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  7. Europe Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  8. East Asia Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  10. Latin America Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Monoclonal Antibodies Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis By Market, 2018 – 2022
      1. By Country
      2. By Source Type
      3. By Production Type
      4. By Application
      5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast By Country, 2023 – 2031
      1. GCC
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast By Source Type, 2023 – 2031
      1. Human
      2. Murine
      3. Chimeric
      4. Humanized
    5. Current Market Size (US$ Mn) Analysis and Forecast By Production Type, 2023 – 2031
      1. In Vivo
      2. In Vitro
    6. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 – 2031
      1. Infectious Diseases
      2. Neurological Diseases
      3. Autoimmune Diseases
      4. Oncology
      5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2031
      1. Hospitals
      2. Specialty Centers
      3. Academical and  Research Institutes
      4. Biopharma Companies
      5. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2023
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. F. Hoffmann-La Roche Ltd 
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Novartis AG
      3. Pfizer Inc
      4. GlaxoSmithKline plc
      5. Merck & Co., Inc.
      6. Amgen Inc.
      7. Daiichi Sankyo Company, Limited
      8. Abbott Laboratories
      9. AstraZeneca plc
      10. Johnson & Johnson Services, Inc.
      11. Bayer AG
      12. Bristol Myers Squibb
      13. F. Hoffman-La Roche Ltd.
      14. Biogen Inc.
      15. Thermo Fisher Scientific, Inc.
      16. Novo Nordisk A/S
      17. Sanofi S.A.
      18. Lonza
      19. ose-immuno
      20. AbbVie Inc. 
      21. UCB S.A.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Thank you for taking time to visit our website, click like if you found the information on this page useful?

View All Reports
Research Methodology
Contact Us
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate